Amgen, Inc. (AMGN) Tops Q2 EPS by 30c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
Amgen (AMGN) PT Raised to $135 at BMO Capital
July 30, 2014 9:11 AM EDTBMO Capital analyst Jim Birchenough reiterated a Market Perform rating and bumped his price target on Amgen (NASDAQ: AMGN) to $135.00 (from $125.00) following Q2 results
Birchenough comments, "While AMGN continues to execute well on generating a return from legacy products, we believe that transformational growth... More
Amgen (AMGN) PT, Estimates Raised at Piper Jaffray Following 'Robust' Q2
July 30, 2014 9:07 AM EDTPiper Jaffray analyst Joshua Schimmer reiterated an Overweight rating and boosted his price target on Amgen (NASDAQ: AMGN) to $150.00 (from $143.00) following "robust" Q2 results after the close.
Schimmer comments, "AMGN reported a robust 2Q after the close, with total revenue of $5.18B... More
